Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

777 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?
Patriarca F, Giaccone L, Onida F, Castagna L, Sarina B, Montefusco V, Mussetti A, Mordini N, Maino E, Greco R, Peccatori J, Festuccia M, Zaja F, Volpetti S, Risitano A, Bassan R, Corradini P, Ciceri F, Fanin R, Baccarani M, Rambaldi A, Bonifazi F, Bruno B. Patriarca F, et al. Among authors: baccarani m. Expert Opin Biol Ther. 2017 Jul;17(7):821-836. doi: 10.1080/14712598.2017.1324567. Epub 2017 May 22. Expert Opin Biol Ther. 2017. PMID: 28506131 Review.
Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors.
Arpinati M, Chirumbolo G, Saunthararajah Y, Stanzani M, Bonifazi F, Bandini G, Baccarani M, Rondelli D. Arpinati M, et al. Among authors: baccarani m. Biol Blood Marrow Transplant. 2007 Feb;13(2):228-34. doi: 10.1016/j.bbmt.2006.10.004. Biol Blood Marrow Transplant. 2007. PMID: 17241928 Free article.
Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation.
Arpinati M, Chirumbolo G, Urbini B, Bonifazi F, Bandini G, Saunthararajah Y, Zagnoli A, Stanzani M, Falcioni S, Perrone G, Tura S, Baccarani M, Rondelli D. Arpinati M, et al. Among authors: baccarani m. Biol Blood Marrow Transplant. 2004 Feb;10(2):106-15. doi: 10.1016/j.bbmt.2003.09.005. Biol Blood Marrow Transplant. 2004. PMID: 14750076 Free article. Clinical Trial.
Allogeneic graft CD34(+) cell dose correlates with dendritic cell dose and clinical outcome, but not with dendritic cell reconstitution after transplant.
Urbini B, Arpinati M, Bonifazi F, Chirumbolo G, Falcioni S, Stanzani M, Bandini G, Motta MR, Perrone G, Giannini B, Tura S, Baccarani M, Rondelli D. Urbini B, et al. Among authors: baccarani m. Exp Hematol. 2003 Oct;31(10):959-65. doi: 10.1016/s0301-472x(03)00232-7. Exp Hematol. 2003. PMID: 14550812 Free article.
Advances in the treatment for haematological malignancies.
Piccaluga PP, Martinelli G, Baccarani M. Piccaluga PP, et al. Among authors: baccarani m. Expert Opin Pharmacother. 2006 Apr;7(6):721-32. doi: 10.1517/14656566.7.6.721. Expert Opin Pharmacother. 2006. PMID: 16556088 Review.
Imatinib mesylate in the treatment of hematologic malignancies.
Piccaluga PP, Rondoni M, Paolini S, Rosti G, Martinelli G, Baccarani M. Piccaluga PP, et al. Among authors: baccarani m. Expert Opin Biol Ther. 2007 Oct;7(10):1597-611. doi: 10.1517/14712598.7.10.1597. Expert Opin Biol Ther. 2007. PMID: 17916051 Review.
777 results